Good broker research note out on XTD the other day, price target is only 32c, but with a lot of scope for upside and upgrades.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025